VoxNeuro Announces Collaboration with the Canadian Armed Forces and Launch of Clinical Study Measuring Impact of Training-Related Sub-Concussive Exposure
ORIGINAL PRESS RELEASE, Business Wire, September 27, 2022 TORONTO–(BUSINESS WIRE)–VoxNeuro Inc. (“VoxNeuro” or the “Company”), a commercial stage Software-as-a-Medical-Device (SaMD) brain health company that analyzes brain biomarkers to assess cognitive function, has announced a new partnership with the Canadian Armed…